Boehringer Ingelheim

Did you know that the kidneys and the heart are deeply connected? The #BeatsOfChange series shines a light on the vital connection between our heart and kidneys, reminding us how intertwined our health truly is.    Professor Smeeta Sinha explores the strong link between chronic kidney disease (CKD) and cardiovascular disease, and why greater awareness of silent diseases like CKD matters.     💡Early identification of CKD, with a UACR urine and eGFR blood test, can help protect both the kidneys and the heart.      🎥 Watch to hear powerful stories from experts and patients about prevention, awareness, and action: https://lnkd.in/e8V2TnfJ    #LifeForward

In recognition of #WorldMentalHealthDay, the Foundation Fighting Blindness invites eye care professionals to join an important upcoming webinar: Seeing Beyond Vision Loss: A Focus on Mental Health Resources for Patients with Retinal Disease Date: Tuesday, November 11, 2025 Time: 7:00 p.m. ET Location: Online via Zoom (registration required) This one-hour discussion will bring together leading experts and advocates to explore how a holistic, compassionate approach to care can improve overall wellness and outlook for patients and their loved ones. Learn more and register at: https://bit.ly/4mYJFt2

#NEWS: We’re starting a new partnership with Aimed Bio Inc., a biotech company that specializes in antibody-based #cancer therapies.  This collaboration will help advance our antibody-drug conjugate (ADC) portfolio - tapping into a leading therapeutic approach. Together, we’re aiming to precisely tackle a broad range of cancers, including those that are hard to treat.   Learn more: https://lnkd.in/e9qdeNaD  #Oncology

#NEWS: Today we presented pivotal data from our Phase III clinical study of our investigational prescription digital therapeutic that evaluated negative symptoms of schizophrenia at the European College of Neuropsychopharmacology (ECNP) Congress and full results will be published at a later date.   We remain grateful to everyone involved in this study and to our valued partners, Click Therapeutics, Inc., for their collaboration.   Learn more: https://lnkd.in/eDxnPEq6

#NEWS: The U.S. Food and Drug Administration (FDA) has approved the first new treatment for idiopathic pulmonary fibrosis (#IPF) in over a decade. Idiopathic #PulmonaryFibrosis is a serious condition that can cause irreversible lung damage and continued decline in lung function.  Learn more here: https://lnkd.in/dmGDPvAM #LifeForward

More efficient research. Faster drug discovery. A smaller environmental footprint. This isn’t just a vision, it’s becoming reality.  We're combining the expertise of our scientists with digital tools and building collaborations with our animal and human pharma colleagues and external partners. Together, we make better decisions faster, focus on the most promising therapies, and develop preventive treatments that help animals live healthier, longer lives.    Read the full article to see how we are using AI and digital tools to drive breakthroughs in animal health: https://lnkd.in/eS-9AU7z

Vaccination plays a vital role in building stronger immunity and improving the health of birds. We're currently at the World Veterinary Poultry Association Congress (WVPAC) in Kuching, Malaysia to discuss innovative vaccine technologies and comprehensive poultry health solutions including biosecurity and surveillance. Learn more about vaccination and poultry immune health here: https://lnkd.in/e_2W5NnN

#NEWS: To help improve diabetes care for patients in underserved communities in Mexico, we've invested in Clínicas del Azúcar through our Social Engagement Fund. This investment builds on a long-standing relationship and marks the Fund’s first expansion into Latin America. It will support the opening of four new specialized diabetes care clinics across the country. The investment aligns with our sustainability commitment to expand access to healthcare for 50 million people by 2030. Learn more here: https://lnkd.in/egzYZmFT

🌍 Did you know that 850 million people are living with chronic kidney disease (CKD) worldwide, with many unaware?    CKD often has no symptoms in the early stages, yet it can significantly increase the risk of cardiovascular disease.  With a simple urine and a blood test, CKD can be identified sooner, helping to protect both your kidney and heart health.    🎥 In #BeatsofChange, Lynn’s journey with cardiovascular disease meets expert insights, revealing why early testing matters and how awareness could transform millions of lives.    👉 Watch now to learn more: https://lnkd.in/eFP3xkDW   #LifeForward

🌟 October is just a few days away, and so is Blindness Awareness Month! This year’s #ShareYourVision campaign celebrates the power of personal perspective — because no two eyes see alike, and no two stories are the same. Your story has the power to inspire, educate, and show the many ways people experience the world. Starting October 1, share your story through written word, audio, or video using #ShareYourVision — and don’t forget to tag us so we can help share it, too! https://lnkd.in/e29Pk26z Image Description: Dark blue background with the Foundation Fighting Blindness logo in the top left and to the right is the text, “Blindness Awareness Month 2025.” Seven headshots are highlighted, each enclosed within a stylized speech bubble frame.